Literature DB >> 22997148

Impaired growth, hematopoietic colony formation, and ribosome maturation in human cells depleted of Shwachman-Diamond syndrome protein SBDS.

Gulay Sezgin1, Adrianna L Henson, Abdallah Nihrane, Sharon Singh, Max Wattenberg, Pascale Alard, Steven R Ellis, Johnson M Liu.   

Abstract

BACKGROUND: Shwachman-Diamond syndrome (SDS), associated with SBDS mutations, is characterized by pancreatic exocrine dysfunction and marrow failure. Sdo1, the yeast ortholog of SBDS, is implicated in maturation of the 60S ribosomal subunit, with delayed export of 60S-like particles from the nucleoplasm when depleted. Sdo1 is needed for release of the anti-subunit association factor Tif6 from 60S subunits, and Tif6 may not be recycled to the nucleus when Sdo1 is absent.
METHODS: To clarify the role of SBDS in human ribosome function, TF-1 erythroleukemia and A549 lung carcinoma cells were transfected with vectors expressing RNAi against SBDS.
RESULTS: Growth and hematopoietic colony forming potential of TF-1 knockdown cells were markedly hindered when compared to controls. To analyze the effect of SBDS on 60S subunit maturation in A549 cells, subunit localization was assessed by transfection with a vector expressing a fusion between human RPL29 and GFP: we found a higher percentage of SBDS-depleted cells with nuclear localization of 60S subunits. Polysome analysis of TF-1 knockdown cells showed a decrease in free 60S and 80S subunits. We also analyzed the levels of eIF6 (human ortholog of Tif6) following near-complete knockdown of SBDS in TF-1 cells and found an approximately 20% increase in the amount of eIF6 associated with the 60S subunit.
CONCLUSIONS: We conclude that knockdown of SBDS leads to growth inhibition and defects in ribosome maturation, suggesting a role for wild-type SBDS in nuclear export of pre-60S subunits. Furthermore, knockdown of SBDS may interfere with eIF6 recycling.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22997148     DOI: 10.1002/pbc.24300

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  7 in total

Review 1.  Marrow failure: a window into ribosome biology.

Authors:  Davide Ruggero; Akiko Shimamura
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

2.  Functional analysis of a novel glioma antigen, EFTUD1.

Authors:  Katsuya Saito; Yukihiko Iizuka; Shigeki Ohta; Satoshi Takahashi; Kenta Nakamura; Hideyuki Saya; Kazunari Yoshida; Yutaka Kawakami; Masahiro Toda
Journal:  Neuro Oncol       Date:  2014-07-11       Impact factor: 12.300

3.  Impaired ribosomal subunit association in Shwachman-Diamond syndrome.

Authors:  Nicholas Burwick; Scott A Coats; Tomoka Nakamura; Akiko Shimamura
Journal:  Blood       Date:  2012-10-31       Impact factor: 22.113

4.  In Vivo Senescence in the Sbds-Deficient Murine Pancreas: Cell-Type Specific Consequences of Translation Insufficiency.

Authors:  Marina E Tourlakis; Siyi Zhang; Heather L Ball; Rikesh Gandhi; Hongrui Liu; Jian Zhong; Julie S Yuan; Cynthia J Guidos; Peter R Durie; Johanna M Rommens
Journal:  PLoS Genet       Date:  2015-06-09       Impact factor: 5.917

Review 5.  Ribosomopathies: mechanisms of disease.

Authors:  Hani Nakhoul; Jiangwei Ke; Xiang Zhou; Wenjuan Liao; Shelya X Zeng; Hua Lu
Journal:  Clin Med Insights Blood Disord       Date:  2014-08-14

6.  SBDS-Deficient Cells Have an Altered Homeostatic Equilibrium due to Translational Inefficiency Which Explains their Reduced Fitness and Provides a Logical Framework for Intervention.

Authors:  Piera Calamita; Annarita Miluzio; Arianna Russo; Elisa Pesce; Sara Ricciardi; Farhat Khanim; Cristina Cheroni; Roberta Alfieri; Marilena Mancino; Chiara Gorrini; Grazisa Rossetti; Ivana Peluso; Massimiliano Pagani; Diego L Medina; Johanna Rommens; Stefano Biffo
Journal:  PLoS Genet       Date:  2017-01-05       Impact factor: 5.917

Review 7.  Ribosomopathies: Global process, tissue specific defects.

Authors:  Pamela C Yelick; Paul A Trainor
Journal:  Rare Dis       Date:  2015-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.